Abbvie Inc. $7,987,454 Acelyrin, Inc. $244,000 Neumora Therapeutics, Inc. $6,047,473 Abbvie Inc. $7,987,454 Acelyrin, Inc. $244,000 Neumora Therapeutics, Inc. $6,047,473